folic acid has been researched along with Central Nervous System Neoplasm in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (50.00) | 29.6817 |
| 2010's | 2 (33.33) | 24.3611 |
| 2020's | 1 (16.67) | 2.80 |
| Authors | Studies |
|---|---|
| Dutta, B; Hassan, P; Hazari, PP; Mishra, AK; Patravale, V; Upadhaya, P | 1 |
| Hayano, A; Takashima, Y; Yamanaka, R | 1 |
| Guenther, M; Hebart, H; Herrlinger, U; Knop, S; Korfel, A; Kurzwelly, D; Linnebank, M; Loeffler, J; Simon, M; Thiel, E; Weller, M | 1 |
| Fliessbach, K; Glasmacher, A; Heun, R; Klockgether, T; Kölsch, H; Linnebank, A; Linnebank, M; Pels, H; Schlegel, U; Schmidt, S; Schmidt-Wolf, IG | 1 |
| Farmand, S; Fliessbach, K; Kleczar, N; Klockgether, T; Linnebank, M; Orlopp, K; Pels, H; Schlegel, U; Schmidt-Wolf, IG; Urbach, H | 1 |
| Hongeng, S; Kajanachumpol, S; Lusawat, A; Nuchprayoon, I; Pakakasama, S; Phudhicharoenrat, S; Shuangshoti, S; Sirachainan, N; Visudtibhan, A; Wongruangsri, S | 1 |
6 other study(ies) available for folic acid and Central Nervous System Neoplasm
| Article | Year |
|---|---|
Radiolabelled folate micellar carriers as proposed diagnostic aid for CNS tumors by nasal route.
Topics: Administration, Intranasal; Animals; Brain Neoplasms; Central Nervous System Neoplasms; Folic Acid; Mice; Micelles; Rats; Tissue Distribution | 2023 |
Cell-type-specific sensitivity of bortezomib in the methotrexate-resistant primary central nervous system lymphoma cells.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bortezomib; Cell Line, Tumor; Central Nervous System Neoplasms; Drug Resistance, Neoplasm; Folic Acid; Gene Expression Regulation, Neoplastic; Humans; Lymphoma; Lymphoma, Non-Hodgkin; Methotrexate; Methylenetetrahydrofolate Dehydrogenase (NADP); Minor Histocompatibility Antigens; Molecular Targeted Therapy; Peptide Synthases; Thymidylate Synthase | 2019 |
Genetic variants of folate and methionine metabolism and PCNSL incidence in a German patient population.
Topics: Adult; Aged; Aged, 80 and over; Central Nervous System Neoplasms; Female; Folic Acid; Genetic Predisposition to Disease; Genotype; Germany; Humans; Incidence; Lymphoma; Male; Methionine; Middle Aged; Polymorphism, Single Nucleotide; White People | 2010 |
The methionine synthase polymorphism D919G alters susceptibility to primary central nervous system lymphoma.
Topics: 5-Methyltetrahydrofolate-Homocysteine S-Methyltransferase; Aged; Case-Control Studies; Cell Transformation, Neoplastic; Central Nervous System Neoplasms; DNA, Neoplasm; Female; Folic Acid; Genetic Predisposition to Disease; Homocysteine; Humans; Lymphoma; Male; Middle Aged; Odds Ratio; Polymorphism, Genetic | 2004 |
MTX-induced white matter changes are associated with polymorphisms of methionine metabolism.
Topics: Aged; Brain; Central Nervous System Neoplasms; Demyelinating Diseases; DNA Mutational Analysis; Drug Resistance; Female; Folic Acid; Folic Acid Antagonists; Gene Frequency; Genetic Predisposition to Disease; Genetic Testing; Haplotypes; Humans; Lymphoma; Male; Methionine; Methotrexate; Middle Aged; Myelin Sheath; Nerve Fibers, Myelinated; Neurotoxins; Polymorphism, Genetic; Risk Factors; S-Adenosylmethionine | 2005 |
Folate pathway genetic polymorphisms and susceptibility of central nervous system tumors in Thai children.
Topics: 5-Methyltetrahydrofolate-Homocysteine S-Methyltransferase; Case-Control Studies; Central Nervous System Neoplasms; Child; Female; Folic Acid; Humans; Male; Membrane Transport Proteins; Methylenetetrahydrofolate Reductase (NADPH2); Polymorphism, Genetic; Reduced Folate Carrier Protein; Thailand; Thymidylate Synthase | 2008 |